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Introduction: Incomplete coronary revascularization is associated with suboptimal outcomes. 
We investigated the long-term effects of Incomplete, Complete and Supra-complete 
revascularization and whether these effects differed in the setting of single-arterial and multi-
arterial CABG.  
Methods: We analyzed 15-year mortality in 7,157 CABG patients [64.1±10.5 years; 30% 
women]. All patients received a left internal thoracic artery to left anterior descending coronary 
artery graft with additional venous grafts only (single-arterial) or with at least one additional 
arterial graft (multi-arterial) and were grouped based on a completeness of revascularization 
index (CRI = number of grafts minus the number of diseased principal coronary arteries: 
Incomplete [CRI≤-1 (N=320;4.5%)]; Complete [CRI=0 (N=2882;40.3%); reference group]; and 
two Supra-complete categories [CRI=+1(N=3050; 42.6%); CRI≥+2(N=905; 12.6%)]. Risk-adjusted 
mortality hazard ratios (AHR) were calculated using comprehensive propensity score 
adjustment by Cox regression. 
Results: Incomplete revascularization was rare (4.5%) but associated with increased mortality in 
all patients [AHR(95%CI)=1.53(1.29-1.80)], those undergoing single-arterial CABG 
[AHR=1.27(1.04-1.54) and multi-arterial CABG [AHR=2.18(1.60-2.99)] as well as in patients with 
3-Vessel  [AHR=1.37(1.16-1.62)] and, to a lesser degree, with 2-vessel [AHR=1.67(0.53-5.23)] 
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incrementally decreased mortality in all patients [AHR(CRI=+1)=0.94(0.87-1.03); 
AHR(CRI≥+2)=0.74(0.64-0.85)], and was driven by a significantly decreased mortality risk in 
single-arterial CABG [AHR(CRI=+1)=0.90(0.81-0.99); AHR(CRI≥+2)=0.64(0.53-0.78)]; and 3-Vessel 
disease  patients [AHR(CRI=+1)=0.94(0.86-1.04); and AHR(CRI≥+2)=0.75 (0.63-0.88)] with no 
impact in multi-arterial CABG [AHR(CRI=+1)=1.07(0.91-1.26); AHR(CRI≥+2)=0.93(0.73-1.17)] 
 Conclusions: Incomplete revascularization is associated with decreased late survival, 
irrespective of grafting strategy. Alternatively, supra-complete revascularization is associated 
with improved survival in patients with 3-Vessel CAD, and in single-arterial but not multi-
arterial CABG. 
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Coronary artery bypass grafting (CABG) remains the optimal treatment for multi-vessel 
coronary artery disease (CAD).1-3 Certain surgeon decisions may substantially impact late CABG 
outcomes. Among these are: 1) the extent to which normal myocardial perfusion is restored, or 
completeness of revascularization4-12 and 2) the choice of arterial versus venous conduits as 
coronary grafts.13-16 
Incomplete coronary revascularization has been repeatedly associated with worse 
survival after CABG, leading surgeons to adopt strategies to facilitate complete 
revascularization.4-6 One approach to accomplish complete revascularization focuses on the 
construction of one graft for each major diseased coronary artery system.7-9 Another approach 
to complete revascularization entails placement of grafts to all diseased  coronary vessels 
supplying viable myocardium, even within the same coronary system.10-12 This approach 
necessarily entails a higher number of grafts, but whether this technique translates to 
incrementally improved survival has not been systematically assessed.11  
Concurrently, compared to the standard-of-care single arterial left internal thoracic 
artery (LITA)-based CABG with only additional saphenous vein grafts (SVG), a number of studies 
have demonstrated improved late CABG survival with multi-arterial CABG achieved by the 
additional use of either the right-ITA or radial artery (RA) grafts.13-16 Whether multi-arterial 
grafting modifies the effect of the completeness of revascularization on late survival is not well 
elucidated. One recent study suggested that multi-arterial grafts mitigated the unfavorable 
long-term effects of incomplete revascularization, but the investigators did not differentiate 
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 The current study analyzed a large CABG experience in multi-vessel CAD patients to test 
the hypothesis that compared to complete revascularization, incomplete revascularization is 
associated with decreased late survival, and that Supra-complete revascularization results in 
incrementally improved late survival. A secondary aim of this analysis was to examine whether 
these effects are modified in case of multi-arterial compared to single-arterial CABG. 
METHODS 
This study is a retrospective analysis of prospectively collected cardiac surgery 
databases from two Ohio hospitals [Mercy Saint Vincent Medical Center (1994-2007) and 
University of Toledo Medical Center (2000-2011), Toledo, Ohio]. Patient data were collected in 
accordance with the Society of Thoracic Surgeons (STS) Cardiac Surgery Database and did not 
involve further patient contact or hospital record reviews. Institutional Review Boards from 
both medical centers approved this study and waived the need for patients’ informed consent. 
Patients who underwent primary CABG surgery for multi-vessel CAD and received a LITA to left 
anterior descending coronary artery (LAD) graft were included in the study. Patients were 
excluded from analysis in case of emergency-salvage, re-operation, no LITA, preoperative renal 
failure, or in case of concomitant valvular or aortic surgery. We defined completeness of 
revascularization index (CRI) as the difference between the number of coronary grafts and the 
number of diseased coronary systems.18 Each distal anastomosis was counted as a separate 
graft. Thus a single sequential conduit counted as more than one graft. Patients were grouped 
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40.3%)]; and two levels of Supra-complete [CRI=+1 (N=3050; 42.6%); CRI≥+2 (N=905; 12.6%)] 
revascularization.  
Surgical Technique. The surgical techniques have been described previously.14,16 The 
radial artery was used in 41% of the study population. Bilateral internal thoracic artery (BITA) 
grafting was used infrequently (2.6%).  
Follow-up. The primary outcome was long-term all-cause mortality. Long-term mortality 
data was obtained from recurrent searches of the US Social Security Death Index (SSDI) 
database (http://ssdi.genealogy.rootsweb.com), last search November 2011 as this was no 
longer a valid research tool thereafter.19 The available study follow-up period ranged between 3 
and 189 months. 
Statistical Methods  
Continuous data were presented as mean ± standard deviation and categorical data as 
percentages. Univariate comparisons were done with chi-square (X2) and Student t-test or 
ANOVA test as appropriate with applied Bonferroni correction. Patient demographics, risk 
factors and operative variables exhibited significant differences across CRI Cohorts (Table 1), for 
single-arterial versus multi-arterial grafting (Table S-1; online supplement), as well as the 2-
vessel and 3-vessel coronary artery disease subgroups (Table S-2; online supplement).  
Propensity-score adjustment was used as the main method to account for these 
imbalances and associated confounding in all analyses. The primary analysis comparing survival 
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also done in four specific patient sub-cohorts – each based on a cohort-specific propensity 
score model: single-arterial CABG, multi-arterial CABG, 2-Vessel disease, and 3-Vessel disease.   
For each analysis, a propensity score predicting the probability of CRI=0 (reference 
category) versus all other sub-groups combined was calculated using a non-parsimonious 
logistic regression model based on 37 demographic, comorbidity, risk factor, surgical priority 
and graft type variables (Table 1). Highly collinear variables were avoided. Given the long study 
period (1994-2011), the year of the surgery was included in the propensity score calculation. 
The resulting propensity scores for the CRI sub-cohorts were distinctly different in all 
comparisons. Unadjusted (HR) and propensity score adjusted hazard ratios [AHR (95% 
confidence intervals)] were derived by Cox regression analysis assuming proportional hazards. 
Derived AHRs were confirmed using comprehensive risk adjusted Cox regression including all 
patient factors in the propensity score models. Predictors of incomplete (CRI≤-1) and supra-
complete revascularization (CRI=+1 and CRI≥+2) were obtained using binary logistic regression 
with the complete revacularization (CRI=0) group used as the reference category (Backward 
selection). A p value less than 0.05 was used to indicate statistical significance. Analysis was 
done using SPSS version 21 software (IBM, Armonk, NY). 
RESULTS 
The total study population consisted of 7157 (72%) multi-vessel CABG patients drawn 
from the overall CABG population of 9865 performed between 1994 and 2011. Mean age and 
female sex decreased with increasing CRI (both p≤0.001), while cardiopulmonary bypass times 
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triple vessel disease were also different among CRI groups (all p≤0.001). Generally, incomplete 
revascularization (CRI≤-1) patients had higher prevalence of comorbidities (peripheral vascular 
disease, cerebrovascular disease, chronic obstructive lung disease; all p≤0.001), but incomplete 
revascularization was not independently associated with a higher operative mortality risk (Table 
1). Despite increased time on cardiopulmonary bypass and a longer aortic cross clamp time, 
higher levels of CRI did not carry an increased acute operative mortality (CRI≤-1: 1.9%, CRI=0: 
1.6%, CRI=+1: 1.4%, CRI≥+2: 0.9%; p=0.44).  
Patient and operative factors were also substantially different when compared for the 
single-arterial (n=4015; 56%) versus multi-arterial (n=3142; 44%) sub-cohorts [Table S-1] and 
for the 2-Vessel disease (n=1564; 22%) versus 3-Vessel disease (n=5593; 78%) sub-cohorts 
[Table S-2; online supplement]. Multi-arterial CABG patients were younger, more male, with a 
higher prevalence of 3-Vessel disease and lower prevalence of insulin-dependent diabetes 
compared to single-arterial counterparts (all p≤0.001). Notably, the distribution of the CRI 
differed significantly for single-arterial and multi-arterial CABG patients (p≤0.001). The most 
common level of CRI in single-arterial was CRI=0(45.6%) followed by CRI=+1(40.1%), while this 
was reversed in multi-arterial CABG patients [CRI=0(33.4%), CRI=+1(45.8%)]. CABG 
corresponding to a CRI≥+2 was performed in 8.2% of single-arterial and 17.8% of multi-arterial 
CABG patients. Increasing levels of CRI was accomplished by increasing both venous and radial 
artery grafts (Table 1): CRI≤-1(SVG-61.6%, RA-25.9%) and CRI≥+2(SVG-97.8%, RA-57.2%).   
Incomplete revascularization (CRI≤-1) was relatively rare, found only in 4.5% of all 
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p<0.001) and single-arterial versus multi-arterial CABG patients (5.6% vs 3.0%, p<0.001). 
Predictors of incomplete revascularization were: female sex [OR(95% Confidence Interval): 
1.39(1.06-1.81)], age [1.02(1.00-1.03) per year], body surface area [1.69(0.99-2.86) per m2], 
peripheral vascular disease [1.66(1.27-2.17)] and 3-Vessel Disease [5.91(3.50-9.96)]. A majority 
of patients received Supra-complete revascularization (55.2%; CRI=+1 and CRI≥+2 groups), and 
these were more frequent among multi-arterial versus single-arterial CABG patients (63.6% vs 
48.7%; p<0.001), in men [OR(95% Confidence Interval), 1.66(1.50-1.85], in patients with 
diabetes [1.15(1.03-1.29); insulin-dependent: 1.31(1.13-1.53)], and less likely in patients with 
peripheral vascular disease [0.81(0.71-0.92)), cerebrovascular disease [0.80(0.72-0.90)], 
previous PCI [0.82(0.72-0.92)], and 3-Vessel disease [0.87(0.78-0.98)]. 
Long-term survival 
Unadjusted survival based on CRI category are shown in Figure 1 (Top, middle, bottom) 
for the all patients, single-arterial CABG, and multi-arterial CABG cohorts, respectively. Figure 2 
shows the unadjusted Kaplan Meier survival comparison for CRI groups in patients with 2-
Vessel disease and 3-Vessel disease. Generally, Incomplete revascularization (CRI≤-1) 
consistently showed worse survival, compared to complete revascularization (CRI=0), 
irrespective of arterial grafting strategy or degree of vessel disease. Alternatively, increasing 
levels of CRI (+1, or ≥+2) showed incrementally improved survival, compared to complete 
revascularization (CRI=0), in case of single-arterial CABG and 3-Vessel disease but not for multi-
arterial CABG. The associated unadjusted hazard ratios (±95% Confidence Interval) are 
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Figure 3 summarizes the adjusted hazard ratios across the various revascularization 
categories for all patients, as well as for arterial grafting strategy [Figure 3 (Left)] and Vessel 
disease [Figure 3 (Right)] subcohorts. These risk-adjusted analyses confirmed the significantly 
worse survival with incomplete revascularization in essentially all cases:  All-Patients {[HR(95% 
CI): 1.53(1.29-1.80)], single-arterial CABG [1.27(1.04-1.54)], multi-arterial CABG [2.08(1.52-
2.84)], 3-Vessel Disease [1.37(1.16-1.62)]}. The 2-Vessel disease cohort was small (n=15) and 
the trend toward worse survival did not reach statistical significance [1.67(0.53-5.23)]. Notably, 
despite the small number of patients (n=94), the deleterious effects of incomplete 
revascularization were more pronounced in case of multi-arterial CABG compared to single-
arterial. Increasing CRI (CRI=0, +1, or ≥+2) showed incrementally decreased mortality in the 
overall study cohort. This effect of supra-complete revascularization was more substantial and 
significant in case of single-arterial CABG [CRI=+1: 0.90(0.81-0.99), CRI=≥+2: 0.64(0.53-0.78)] 
but not multi-arterial CABG [CRI=+1: 1.07(0.91-1.26), CRI=≥+2: 0.93(0.73-1.17)]. Lastly, 
increasing levels of CRI was particularly beneficial in patients with 3-Vessel CAD and less so in 





In this large CABG experience with a substantial use of multiple arterial conduits, our 
findings confirm that although incomplete revascularization (CRI≤-1) does not increase peri-
operative mortality, it is associated with a significantly increased 15-year mortality. 
Furthermore, increasing the number of coronary grafts to achieve Supra-complete 
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results in an incremental systematic decrease in late mortality without any appreciable increase 
in perioperative risk inherent to increased operative times required to achieve this grafting 
strategy. This survival benefit of a supra-complete revascularization is particularly evident in 
case of single-arterial as opposed to multi-arterial CABG, and in patients with 3-Vessel CAD as 
opposed to 2-Vessel CAD. 
 A uniformly accepted definition of incomplete coronary revascularization is lacking and 
hence its impact on late survival is not well defined. Traditionally, incomplete revascularization 
has been defined by the lack of a graft placed to one or more of the three principal epicardial 
coronary systems20 containing a hemodynamically significant lesion. The lack of a graft to any 
coronary target with ≥50% stenosis, even within the same coronary artery system (LAD, 
circumflex or the RCA) has also been considered as an alternative definition of an incomplete 
revascularization.18 Others, using more sophisticated and also more complex criteria, have 
defined incomplete revascularization based on the residual post procedural myocardial 
jeopardy index21, a decremental deviation from an “ab initio” grafting strategy as formulated in 
the Syntax Trial22 or a residual Syntax score greater than zero.23 These varied definitions 
probably contribute to the wide discrepancies in the reported rates of incomplete 
revascularization from 5%24 to 36.822 to as high as 69%21. We report a relatively low overall 
incomplete revascularization rate of 4.5%. 
 Surgeons are generally committed to a complete coronary revascularization aimed at 
fully restoring myocardial perfusion in all coronary vessels supplying viable myocardial 
territories. Unforeseen intra-operative factors (diminutive coronary targets, diffuse 
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minimize operative time) may lead to modification of such a pre-operative plan resulting in 
incomplete revascularization. The literature on the clinical impact of incomplete 
revascularization is split, with some reports indicating significant adverse clinical 
outcomes5,9,21,24,25 while others suggesting a trivial or no impact on clinical end-points.4,17,18,26 
This is crystallized by the results of two separate analyses of the SYNTAX trial data with one 
study concluding that incomplete revascularization did not impact outcomes22, while a follow 
up study found incomplete revascularization was associated with adverse outcomes.23 Our data 
demonstrate that incomplete revascularization is associated with increased late mortality in the 
overall CABG population as well as inpatient sub-cohorts undergoing  single-arterial CABG, 
multi-arterial CABG and in patients with 3-Vessel CAD. This trend did not reach statistical 
significance in 2-Vessel CAD patients, although given the small number of patients in this group 
(n=15 cases only) these results must be interpreted with caution and require confirmation from 
larger analyses. This negative effect of incomplete revascularization was particularly prominent 
in multi-arterial CABG. Our finding differs from other studies. Kieser et al reported no adverse 
long-term outcomes associated with incomplete revascularization in patients younger than 80 
and who underwent predominantly multi-arterial CABG (98%).17 In contradistinction to our 
findings, the authors concluded that multi-arterial grafting mitigates the negative impact of 
incomplete revascularization. In patients older than 80, however, incomplete revascularization 
carried an increased risk of mortality but no explanation behind these findings was provided.17 
We did not study the impact of age on the effects of incomplete revascularization. Rastan et al, 
in a large CABG series with a 21% rate of all arterial grafting, found no difference in survival up 
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revascularization, although the results were not risk adjusted.27 Potential explanations for the 
different findings in our analysis compared to these other studies include: the rate of 
incomplete revascularization in our multi-arterial CABG cohort was quite small (n=94), our 16-
year follow-up was substantially longer, and both the Kieser and Rastan groups had a much 
higher rate of bilateral internal thoracic artery (BITA) use and a much lower radial artery (RA) 
use compared to our multi-arterial cohort. Thus conceivably incomplete revascularization in 
BITA-based multi-arterial CABG may have distinctly different prognosis than in LITA/RA-based 
multi-arterial CABG. 
  A number of preoperative factors were found to be associated with incomplete 
revascularization including female sex, increasing age, increasing body surface area, peripheral 
vascular disease and 3-Vessel disease. Others have also identified older age, diabetes and 
peripheral vascular disease as predictors.23 Conversely, we identified that male sex [OR (95% 
Confidence Interval): 1.66 (1.50-1.85] and diabetes [OR=1.15 (1.03-1.29)] are associated with a 
greater frequency of supra-complete revascularization (CRI=+1 and CRI≥+2). Possibly the larger 
size of coronary targets in males lend themselves to a higher number of grafts, while the more 
diffuse and aggressive diabetic coronary angiopathy may necessitate more grafts per each 
diseased coronary artery system. 
Our data support a supra-complete revascularization, with placement of a coronary 
graft to each diseased target vessel rather than a single conduit to each diseased coronary 
artery system,  particularly in cases of single-arterial CABG and in patients with 3-Vessel CAD. 
Chu et al28 compared risk adjusted 10-year outcomes in Veterans Administration CABG patients 
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diseased coronary system and found no difference in survival with either grafting strategy. The 
fact that 99% of this cohort was male, with a relatively low incidence of triple vessel disease 
(53% vs 78% in the current study) and the exclusive use of the LITA as the only arterial graft, 
may account for the differences in the results. Our finding that a supra-complete 
revascularization strategy is not associated with an incremental survival benefit compared to 
Complete revascularization in patients undergoing multi-arterial CABG may be due to the 
survival benefit associated with the increased durability of arterial grafts compared to venous 
grafts and thus a smaller number of arterial grafts may have a similar impact on survival as a 
larger number of venous grafts. Furthermore, slower progression of atherosclerotic burden 
downstream from arterial grafts compared to venous grafts may also play a role in our 
findings29 suggesting that it is the quality of the grafts rather than quantity of grafts among 
multi-arterial CABG patients that is important. 
The limitations of our study include its retrospective, single practice two institutional 
nature. Our assessment of coronary disease, consistent with the STS database criteria, is rather 
rudimentary based on the number of diseased major coronary artery systems without 
consideration of the specific number of vessels diseased within each system. In addition, our 
CRI calculation includes the number of completed coronary grafts without consideration of the 
specific coronary targets. In certain cases, due t our reliance on the derived CRI metrics, a CRI=0 
designation, may in fact represent an incomplete  revascularization, if the grafts were placed to 
the same coronary artery system leaving diseased vessel in other coronary artery systems 
unreconstructed. The limited granularity of our dataset does not permit this level of detailed 
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atherosclerotic burden, the quality of the target vessels or their size. Also, we are unable to 
categorize the coronary artery lesions as proximal or distal and how much myocardium remains 
at risk by not bypassing them. In addition, our database does not contain the reasons why a 
patient left the operating room with an incomplete revascularization, the details of the 
physiologic significance of the coronary lesions as the severity of each stenosis was exclusively 
based on angiographic assessment rather than their impact on physiologic myocardial perfusion 
or whether a diseased vessel supplied viable or non-viable myocardium. We also do not have an 
assessment of the collateral flow in patients with an incomplete revascularization. Lastly, the 
specific cause of death was unavailable to us to specifically assess the cardiovascular 
consequences of the achieved revascularization.  
In conclusion, our data strongly supports the perspective that incomplete 
revascularization is associated with increased long term mortality regardless of whether a 
patient undergoes single-arterial CABG or multi-arterial CABG. Furthermore, Supra-complete 
revascularization (CRI=+1 and CRI≥+2) compared to complete revascularization (CRI=0), appears 
to be associated with improved long-term survival in patients undergoing single-arterial CABG 
and in those with 3-Vessel disease. In multi-arterial CABG, the incremental benefit of additional 
grafts beyond those required for a complete revascularization is likely of smaller magnitude.  
Given the small numbers of patients within our study subcohorts, our findings should be 
considered hypothesis generating and additional, more granular, confirmatory studies are 
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Figure Legends  
 
Figure 1. Comparison of 15-year survival for the four completeness of revascularization (CRI 
subgroups) shown for the overall cohort (top: All CABG) and separately for the single arterial 
(middle: single-arterial CABG) and multi-arterial (bottom: multi-arterial CABG) sub-cohorts. P 
value reflects the long rank test across all 4 groups (overall). 
 
Figure 2. Comparison of 15-year survival for the four completeness of revascularization (CRI 
subgroups) shown for the 2-vessel disease (top) and 3-vessels disease (bottom) patient sub- 
cohorts. P value reflects the long rank test across all 4 groups (overall). 
 
Figure 3. Propensity score adjusted hazard ratios for 15-year mortality following CABG surgery 
shown for different completeness of revascularization levels (CRI=0 as reference): (Left) overall 
cohort (All CABG) and separately for the single arterial (single-arterial CABG) and multi-arterial 
(multi-arterial CABG) sub- cohorts; (Right) overall cohort (All CABG) and separately for the 2-
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Table 1.  Selected patient demographic, co-morbidity and operative data compared across 
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Table 1.  Selected patient demographic, co-morbidity and operative data compared across 
Completeness of Revascularization (CRI) Subcohorts. 
 
  Completeness of revascularization Index   
Variable 
CRI≤-1         
(N=320) 
CRI=0      
(N=2882) 
CRI=+1   
(N=3050) 
CRI≥+2        
(N=905) p-value *
,# 
      
Categorical Variables % % % %  
Female 34.7% 36.2% 28.2% 17.2% ≤0.001 
BMI  (Kg/m2)        0.274 
            <25 16.3% 17.8% 16.4% 13.5%  
             25-29.9 36.6% 38.4% 39.1% 38.8%  
             30-34.9 29.4% 27.2% 27.8% 28.2%  
             35-39.9 10.9% 10.7% 11.0% 13.4%  
             >40 6.9% 5.9% 5.7% 6.2%  
Smoking 57.5% 62.4% 61.3% 61.2% 0.374 
Family History of CAD 66.6% 65.5% 64.5% 62.2% 0.278 
Diabetes 36.6% 34.5% 35.8% 40.0% 0.029 
           Insulin Dependent 15.9% 10.9% 12.3% 11.5% 0.043 
Hypercholesterolemia 69.1% 71.9% 70.2% 71.3% 0.415 
Hypertension 85.0% 81.0% 80.3% 78.7% 0.086 
Peripheral Vascular Disease 24.7% 17.5% 14.8% 13.7% ≤0.001 
Cerebrovascular Disease 30.3% 25.2% 21.4% 17.8% ≤0.001 
Stroke 10.9% 8.3% 7.4% 6.0% 0.17 
COPD 25.0% 20.5% 20.0% 15.7% ≤0.001 
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Congestive Heart Failure 12.2% 11.5% 10.9% 9.8% 0.466 
Previous PCI 20.6% 19.7% 17.5% 16.9% 0.056 
Three Vessels Disease 95.3% 77.2% 78.6% 73.5% ≤0.001 
Left Main Disease 19.4% 23.8% 22.6% 21.7% 0.218 
      
Operative Variables      
Emergency 5.3%  5.1% 5.6% 5.9% 0.754  
ON-Pump Surgery 96.6% 97.4% 97.9% 96.1% ≤0.001  
Non isolated CABG 10.3% 9.1% 8.8% 10.8% 0.508  
Radial artery graft use 25.9% 33.6% 44.5% 57.2%  ≤0.001 
Saphenous Vein graft use 61.6%  87.5% 96.8% 97.8% ≤0.001 
Bilateral Internal Mammary 
Artery  
 3.4% 2.6% 2.1% 3.9%  0.026 
Peri-op Mortality 1.9% 1.6% 1.4% 0.9% 0.440 
      
Continuous Variables Mean±SD Mean±SD Mean±SD Mean±SD p-value *,# 
Age (years) 66.0±10.7 64.6±10.9 63.9±10.4 62.6±10.0 ≤0.001 
Body Surface area (BSA, m2) 2.03±0.25 2.01±0.25 2.04±0.25 2.09±0.24 ≤0.001 
Ejection Fraction (%) 48±11 50±11 49±11 48±11 ≤0.001 
Cardio-pulmonary Bypass (min) 49±38 68±30 90±31 112±33 ≤0.001 
Cross-Clamp (min) 29±22 41±20 57±22 76±25 ≤0.001 
No. of Grafts 1.91±0.29 2.77±0.42 3.79±0.41 4.87±0.58 ≤0.001 
        Venous  0.62±0.49 1.36±0.69 2.21±0.78 2.88±1.03 ≤0.001 
        Arterial 1.29±0.46 1.41±0.58 1.58±0.70 2.00±0.98 ≤0.001 
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              Radial Artery 0.26±0.44 0.38±0.56 0.54±0.68 0.93±0.98 ≤0.001 
*ANOVA across 4 treatment groups (overall), #chi square across 4 treatment groups (overall), PCI: 
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Figure 3 
